Yueyang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yueyang Li has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Di Wei
CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, China; China National Center for Bioinformation, Beijing, 100101, China
1 shared publication- Kaifeng Niu
Institute of Functional Nano & Soft Materials (FUNSOM) Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices Joint International Research Laboratory of Carbon-Based Functional Materials and Devices Soochow University Ren'ai road No. 199 Suzhou Jiangsu 215123 China
1 shared publication Mengge Li
CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, China; China National Center for Bioinformation, Beijing, 100101, China; University of Chinese Academy of Sciences, Beijing, 100049, China
1 shared publication- Yongliang Zhao
China National Center for Bioinformation, Beijing, China
1 shared publication Yuchun Deng
CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, China; China National Center for Bioinformation, Beijing, 100101, China; University of Chinese Academy of Sciences, Beijing, 100049, China
1 shared publication- Yukun Chen
CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, China; China National Center for Bioinformation, Beijing, 100101, China; University of Chinese Academy of Sciences, Beijing, 100049, China
1 shared publication
Latest Publications
- Open Access
- 19 January 2024
- Published by Elsevier in Experimental Cell Research
- Vol. 435 (2) , 113932
RBM10 regulates the tumorigenic potential of human cancer cells by modulating PPM1B and YBX1 activities
- 19 January 2024
- Published by Elsevier in Experimental Cell Research
- Vol. 435 (2) , 113932
Open AccessRBM10 regulates the tumorigenic potential of human cancer cells by modulating PPM1B and YBX1 activities